Natural killer cells in clinical development as non-engineered, engineered, and combination therapiesNina Lamers-Kok, Monica Raimo, Denise Panella et al.|Journal of Hematology & Oncology|2022Cited by 178
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic MelanomaAmanda van Vliet, Jan Spanholtz, Anna‐Maria Georgoudaki et al.|Cancers|2021Cited by 48
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppressionAnna Rea, Aura Muntasell, Nina Möker et al.|Nature Immunology|2025Cited by 44
Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90Tanmoy Saha, Aaron Goldman, Amanda van Vliet et al.|Frontiers in Molecular Biosciences|2021Cited by 10
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activityAmanda van Vliet, Monica Raimo, Mirjam G.C.N. van den Hout et al.|Molecular Therapy Oncology|2024Cited by 9